AuroMedics Pharma LLC has recalled Mirtazapine (mirtazapine) 15 mg and 7.5 mg tablets in 500-count bottles because some bottles were mislabeled with the wrong strength. Some cases labeled as 15 mg tablets contain bottles labeled as 7.5 mg, which could lead to patients taking the incorrect dosage. Consumers should contact their healthcare provider or pharmacist immediately to determine if their medication is affected and to discuss potential health impacts.
A labeling error regarding the drug strength can lead to patients taking a significantly higher or lower dose of medication than prescribed. Taking an incorrect dose of Mirtazapine, which is used for treating depression, can result in ineffective treatment or unintended side effects.
Healthcare provider consultation and pharmacy refund.
“Product label, Aurobindo Pharma USA, Inc. Mirtazapine Tablets, USP 7.5 mg 500 Tablets NDC 13107-001-05”
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.